Patent Number: 7,709,202

Title: Molecular characteristics of non-small cell lung cancer

Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation. The messages of two p53-regulated genes, p21.sup.WAF1/CIP1 and 14-3-3.sigma., were consistently under-expressed in the adenocarcinomas, suggesting that the p53 pathway itself might be compromised in this cancer type. Gene expression observed by SAGE were consistent with the results obtained by quantitative real-time PCR or cDNA array analyses using 43 additional lung tumor and normal samples. Thus, although derived from only a few tissue libraries, molecular signatures of non-small cell lung cancer derived from SAGE most likely represent an unbiased yet distinctive molecular signature for human lung cancer.

Inventors: Nacht; Mariana (Belmont, MA), Dracheva; Tatiana (Rockville, MD), Sidransky; David (Baltimore, MD), Madden; Stephen L (Sudbury, MA), Jen; Jin (Brookeville, MD)

Assignee: The Johns Hopkins University

International Classification: C12Q 1/68 (20060101); C07H 21/02 (20060101); C12P 19/34 (20060101)

Expiration Date: 5/04/12018